Norovirus Utilizes NINJ1 for Selective Secretion of NS1 Prot
2026-06-29
Song et al. reveal that murine norovirus (MNoV) hijacks the host plasma membrane protein NINJ1 to selectively secrete the viral immune antagonist NS1, while simultaneously releasing cellular DAMPs. Through genetic and biochemical approaches, the study establishes NINJ1 as a key regulator of unconventional protein secretion during viral infection, offering new insight into host-pathogen interactions.
Dual-Action p38α MAPK Inhibitors: Mechanisms of Dephosphoryl
2026-06-29
Recent work reveals that certain p38α MAPK inhibitors not only block kinase activity but also accelerate dephosphorylation by stabilizing the kinase in a phosphatase-accessible conformation. This mechanistic insight paves the way for more precise modulation of inflammatory signaling and informs the development of next-generation kinase inhibitors for disease modeling.
Ciprofloxacin Potentiates Ferroptosis via Mitochondrial Zinc
2026-06-28
This study uncovers how ciprofloxacin enhances RSL3-induced ferroptosis in cancer cells by promoting mitochondrial Zn²⁺ accumulation through activation of the STING1–CAV2 pathway. These findings reveal a dual, context-dependent role for ciprofloxacin in ferroptosis regulation, with potential implications for targeted cancer therapies.
NSC23766 Trihydrochloride: Selective Rac1 GTPase Inhibitor I
2026-06-27
NSC23766 trihydrochloride is a selective Rac GTPase inhibitor that disrupts Rac1-GEF interactions, modulating cellular processes central to cancer research. Its efficacy and selectivity are evidenced in both in vitro and in vivo models, with well-documented benchmarks for apoptosis induction and cell cycle arrest. This article synthesizes recent findings, practical workflows, and limitations for researchers.
T-5224 (C-Fos/AP-1 Inhibitor): Mechanisms, Innovations, and
2026-06-26
Explore the advanced molecular mechanisms and translational significance of T-5224, a selective C-Fos/AP-1 inhibitor. This article unveils recent discoveries in ferroptosis, arthritis research, and inflammation modulation, providing unique guidance for experimental design.
InstaBlue Protein Stain Solution: Rapid, Sensitive Gel Visua
2026-06-26
InstaBlue Protein Stain Solution redefines protein gel workflows with instant, high-sensitivity visualization—ideal for demanding biomedical research and mass spectrometry applications. Its unique, non-toxic formula streamlines experimental timelines and preserves protein integrity, enabling advanced studies like those dissecting molecular dysfunction in neurodegenerative disease.
JNK-IN-7: Selective JNK Inhibitor for Advanced Apoptosis Ass
2026-06-25
JNK-IN-7 unlocks highly selective, covalent modulation of JNK signaling, enabling researchers to dissect MAPK-driven apoptosis and innate immune mechanisms with unprecedented precision. Learn how to optimize workflows and troubleshoot common pitfalls when applying JNK-IN-7 to cell-based kinase and immune response assays.
Inflammation in Ischemic Stroke: Biomarkers and Treatment Ad
2026-06-25
Xiao et al. (2025) provide a comprehensive synthesis of the inflammatory mechanisms underlying ischemic stroke, with an emphasis on diagnostic biomarkers and therapeutic strategies. Their review bridges fragmented insights, guiding clinicians and researchers toward more precise and multifaceted interventions.
Practical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling
2026-06-24
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for efficient, reproducible synthesis of fluorescently labeled RNA probes for in situ hybridization and Northern blotting. It is intended exclusively for research use and should not be applied in diagnostic or clinical workflows.
BMAL1 Phase Separation Drives Circadian Transcriptional Hubs
2026-06-23
Gao et al. reveal that BMAL1, a core circadian clock protein, forms phase-separated nuclear condensates that act as dynamic transcriptional hubs, regulated by an intrinsically disordered region and its phosphorylation state. This mechanistic insight clarifies how BMAL1 precisely times circadian gene expression, providing new directions for the study of post-translational modifications in circadian biology.
OSMI-1: Transforming O-GlcNAcylation Research in Preeclampsi
2026-06-23
This thought-leadership article explores how OSMI-1, a potent O-GlcNAc transferase inhibitor from APExBIO, is revolutionizing translational research into ferroptosis and trophoblast syncytialization, with an emphasis on preeclampsia. Drawing on recent mechanistic breakthroughs, we synthesize biological rationale, experimental strategies, and practical protocol guidance for researchers aiming to dissect the O-GlcNAc-HUWE1-TfR1 axis. The article contextualizes OSMI-1’s value versus the competitive landscape and projects future directions in placental biology.
HyperScribe T7 Cy5 RNA Labeling Kit: Precision for Modern RN
2026-06-22
Explore how the HyperScribe T7 High Yield Cy5 RNA Labeling Kit advances in situ hybridization probe preparation with unprecedented yield and flexibility. This article reveals unique mechanistic insights and strategic assay considerations for researchers seeking next-generation fluorescent RNA labeling.
Aclacinomycin A (Aclarubicin): Decoding rDNA Damage and PML
2026-06-22
Explore how Aclacinomycin A, a dual topoisomerase inhibitor, uniquely models persistent rDNA damage and PML-nucleolar compartment formation in cancer research. This article reveals advanced mechanistic insights and experimental strategies for leveraging Aclacinomycin A in genome stability studies.
ABT-737: Applied Workflows for BCL-2 Protein Inhibitor Resea
2026-06-21
ABT-737, a benchmark BCL-2 protein inhibitor, unlocks precise, reproducible apoptosis induction in cancer research. This guide distills current mechanistic insights, advanced workflows, and troubleshooting strategies for maximizing its experimental impact.
Mildronate-Derived Lipidoids Enable Safer mRNA Vaccine Deliv
2026-06-20
The referenced ACS Nano study introduces mildronate-derived cationic lipidoids as an innovative alternative to conventional mRNA lipid nanoparticle components, achieving efficient mRNA vaccine delivery with substantially reduced inflammatory side effects. This advancement addresses a major barrier to mRNA vaccine translation, supporting safer immunogen design and preclinical research.
466 records 14/32 page Previous Next First page 上5页 1112131415 下5页 Last page